Actemra actpen 162 MG/0.9 ML 0.9ML
Ended Awarded
- Contract number
- SPE2DR26FQQ1L
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,864
Award facts
- Contract value 100% obligated
- $13,863.71 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $13,863.71 delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Actemra (tocilizumab) Actpen 162 mg/0.9 mL auto-injector pens. This competitively awarded, firm fixed-price contract has an ultimate completion date of November 18, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract utilizes no set-aside designation and represents a routine pharmaceutical procurement within the Defense Health Supply Chain.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), a $999.999 billion pharmaceutical prime vendor agreement running through December 2026. This comprehensive global pharmaceutical support vehicle enables AmerisourceBergen to supply a wide range of brand-name and generic medications, specialty pharmaceuticals, and medical supplies to support military healthcare programs and the Defense Health Agency worldwide. Actemra is a immunosuppressive biologic therapy commonly used in military and veteran healthcare systems for rheumatologic conditions, reflecting the Defense Health Supply Chain's need for specialized medical treatments across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FQQ1L?
SPE2DR26FQQ1L was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 17, 2025.
How much is contract SPE2DR26FQQ1L worth?
The government has obligated $13,864 on SPE2DR26FQQ1L.
Is contract SPE2DR26FQQ1L an order under another contract?
Yes. SPE2DR26FQQ1L is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQQ1L competed?
The extent of competition for SPE2DR26FQQ1L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award